Are there therapeutic agents that act to activate the GSH system to reduce myocardial injury
The gut microbiome can also play a significant role in how conjugated toxins are moved out through feces or absorbed back into the body.[ref] ABCB1 P-gp efflux transporter for medications, HRT, and environmental toxins SLCO1B1 and ABCG2 statins and muscle pain risk OCTN1 organic cation transporter, ergothionine Detoxification pathways for specific substances: In addition to the phase I and phase II specific genes above, the following articles look at specific toxicants and their detoxification pathways: Mold Genes Arsenic Detoxification BPA Detoxification Glyphosate Detoxification Organophosphate Pesticides Caffeine Metabolism Phthalate Detoxification Lead PFAS Fluoride DPYD 5-fluorouracil toxicity Mercury Molybdenum and copper ALDH2, ADH1B and Alcohol By learning about your genetic variants and their impact on detoxification pathways, you can take proactive steps to support your bodys natural ability to eliminate harmful substances and maintain optimal health
Targeted delivery of anti-osteoporosis therapy: Bisphosphonate-modified nanosystems and composites
Pain Management and Neurological Support: IV magnesium, ketamine (under medical supervision), and other neuroprotective agents help treat migraines, chronic pain, fibromyalgia, and mood disorders
These results collectively demonstrate that GSTA1 reduces the accumulation of LD, highlighting the potential protective role of GSTA1 in hepatic steatosis
